SYNDAX PHARMACEUTICALS INC shareholders Q3 2023

SYNDAX PHARMACEUTICALS INC's ticker is SNDX and the CUSIP is 87164F105. A total of 177 filers reported holding SYNDAX PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.88 and the average weighting 0.3%.

SYNDAX PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
DEUTSCHE BANK AG\ 49,813$723,2850.00%
ALLIANCEBERNSTEIN L.P. 77,460$1,124,7190.00%
Lindbrook Capital, LLC 95$1,3790.00%
GTS SECURITIES LLC 14,403$209,1320.00%
CWM, LLC 327$50.00%
Parallel Advisors, LLC 486$7,0570.00%
SIGNATUREFD, LLC 126$1,8300.00%
Allworth Financial LP 9$1310.00%
NISA INVESTMENT ADVISORS, LLC 64$9290.00%
MASSMUTUAL TRUST CO FSB/ADV 56$8130.00%
Covestor Ltd 6$00.00%
PRICE T ROWE ASSOCIATES INC /MD/ 24,410$3550.00%
Daiwa Securities Group Inc. 242$40.00%
UBS Group AG 75,357$1,094,1840.00%
UBS Group AG 19,800$287,4960.00%
UBS Group AG 60,000$871,2000.00%
Baker Avenue Asset Management, LP 31$4500.00%
ROYAL BANK OF CANADA 11,479$167,0000.00%
Legal & General Group Plc 50,177$728,3830.00%
COMMONWEALTH EQUITY SERVICES, LLC 11,695$1700.00%
External links

This page lists SYNDAX PHARMACEUTICALS INC's shareholders in Q3 2023. To view SYNDAX PHARMACEUTICALS INC's shareholder history, click here.